• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Therabody

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Therabodysee related information
Date Initiated by FirmJune 23, 2026
Date PostedJuly 31, 2026
Recall Status1 Open3, Classified
Recall NumberZ-2835-2026
Recall Event ID 99281
Product Classification Massager, therapeutic, electric - Product Code ISA
ProductCharger for the Therabody Theragun, G4 PRO massage device, and products which include the 4th Generation Theragun PRO charger. G4 PRO Black US - Refurb., SKU TG02428-01 G4 PRO NA, SKU G4-PRO-PKG-NA G4-PRO-PKG-US, SKU G4 PRO US G4 PRO Black US - Refurb V, SKU TG0002428-1V10 Pro Charger Single Unit, SKU PRO-CHARGER-SINGLE
Code Information UDI-DI 00810036050135 Charger GTIN 810036051378 All lots are recalled. Production ended in 2022.
FEI Number 3012386142
Recalling Firm/
Manufacturer
Therabody, Inc
1640 S Sepulveda Blvd Ste 300
Los Angeles CA 90025-7565
For Additional Information ContactCJ Frederick
310-776-0667
Manufacturer Reason
for Recall
Charging cradle for the device may overheat while charging the device's removable battery pack, presenting risk of thermal event (fire). Firm has received reports alleging the product caught fire and other reports regarding visible smoke, melting, charger burn, burning odor, and overheating.
FDA Determined
Cause 2
Under Investigation by firm
ActionOn June 23, 2026, the firm sent a notice to all distributors, retailers, and resellers in the US and Canada titled "STOP SALE AND DISTRIBUTION NOTICE". Recipients were instructed to stop sale, distribution, and transfer of the charger for the Theragun G4 PRO in the United States and Canada. Product should be removed from shelves, displays, and online listings. Product should be segregated and inventory clearly marked as "DO NOT SELL - STOP SALE". Recipients are instructed to not return product to consumers or dispose of inventory. Firm is currently evaluating and addressing the issue.
Quantity in Commerce584224
DistributionWorldwide - US Nationwide distribution.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
-
-